These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30048534)
1. Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection. Jiang M; Leung NH; Ip M; You JHS PLoS One; 2018; 13(7):e0201539. PubMed ID: 30048534 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease. You JHS; Jiang X; Lee WH; Chan PKS; Ng SC J Gastroenterol Hepatol; 2020 Sep; 35(9):1515-1523. PubMed ID: 32017248 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Varier RU; Biltaji E; Smith KJ; Roberts MS; Kyle Jensen M; LaFleur J; Nelson RE Infect Control Hosp Epidemiol; 2015 Apr; 36(4):438-44. PubMed ID: 25782899 [TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France. Baro E; Galperine T; Denies F; Lannoy D; Lenne X; Odou P; Guery B; Dervaux B PLoS One; 2017; 12(1):e0170258. PubMed ID: 28103289 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia. Merlo G; Graves N; Brain D; Connelly LB J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection. Aby ES; Vaughn BP; Enns EA; Rajasingham R Clin Infect Dis; 2022 Oct; 75(9):1602-1609. PubMed ID: 35275989 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Varier RU; Biltaji E; Smith KJ; Roberts MS; Jensen MK; LaFleur J; Nelson RE Clin Microbiol Infect; 2014 Dec; 20(12):1343-51. PubMed ID: 25366338 [TBL] [Abstract][Full Text] [Related]
8. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection. Luo Y; Lucas AL; Grinspan AM Dig Dis Sci; 2020 Apr; 65(4):1125-1133. PubMed ID: 31493042 [TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107 [TBL] [Abstract][Full Text] [Related]
10. Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections. Hocquart M; Lagier JC; Cassir N; Saidani N; Eldin C; Kerbaj J; Delord M; Valles C; Brouqui P; Raoult D; Million M Clin Infect Dis; 2018 Feb; 66(5):645-650. PubMed ID: 29020328 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Konijeti GG; Sauk J; Shrime MG; Gupta M; Ananthakrishnan AN Clin Infect Dis; 2014 Jun; 58(11):1507-14. PubMed ID: 24692533 [TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation and Medical Therapy for Clostridium difficile Infection : Meta-analysis of Randomized Controlled Trials. Singh T; Bedi P; Bumrah K; Gandhi D; Arora T; Verma N; Schleicher M; Rai MP; Garg R; Verma B; Sanaka MR J Clin Gastroenterol; 2022 Nov-Dec 01; 56(10):881-888. PubMed ID: 34516460 [TBL] [Abstract][Full Text] [Related]
13. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. Gupta S; Zhu J; McCarty TR; Pruce J; Kassam Z; Kelly C; Fischer M; Allegretti JR J Gastroenterol Hepatol; 2021 Sep; 36(9):2432-2440. PubMed ID: 33682170 [TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. Rao K; Safdar N J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412 [TBL] [Abstract][Full Text] [Related]
17. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Fischer M; Sipe BW; Rogers NA; Cook GK; Robb BW; Vuppalanchi R; Rex DK Aliment Pharmacol Ther; 2015 Aug; 42(4):470-6. PubMed ID: 26096320 [TBL] [Abstract][Full Text] [Related]
18. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model. Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529 [TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388 [TBL] [Abstract][Full Text] [Related]
20. Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin. Konturek PC; Haziri D; Helfritzsch H; Hess T; Harsch IA Med Princ Pract; 2017; 26(2):182-184. PubMed ID: 27978522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]